Live cell single‐molecule detection in systems biology

Fine-Grained Parallel and Distributed Spatial Stochastic Simulation of Biological Reactions

We describe a fluorescence microscopy method, Co-Translational Activation by Cleavage (CoTrAC) to image the production of protein molecules in live cells with single-molecule precision without perturbing the protein's functionality. This method makes it possible to count the numbers of protein molecules produced in one cell during sequential, five-minute time windows. It requires a fluorescence microscope with laser excitation power density of ~0.5 to 1 kW/cm(2), which is sufficiently sensitive to detect single fluorescent protein molecules in live cells. The fluorescent reporter used in this method consists of three parts: a membrane targeting sequence, a fast-maturing, yellow fluorescent protein and a protease recognition sequence. The reporter is translationally fused to the N-terminus of a protein of interest. Cells are grown on a temperature-controlled microscope stage. Every five minutes, fluorescent molecules within cells are imaged (and later counted by analyzing fluorescence images) and subsequently photobleached so that only newly translated proteins are counted in the next measurement. Fluorescence images resulting from this method can be analyzed by detecting fluorescent spots in each image, assigning them to individual cells and then assigning cells to cell lineages. The number of proteins produced within a time window in a given cell is calculated by dividing the integrated fluorescence intensity of spots by the average intensity of single fluorescent molecules. We used this method to measure expression levels in the range of 0-45 molecules in single 5 min time windows. This method enabled us to measure noise in the expression of the λ repressor CI, and has many other potential applications in systems biology.

The exploding number of computational models produced by Systems Biologists over the last years is an invitation to structure and exploit this new wealth of information. Researchers would like to trace models relevant to specific scientific questions, to explore their biological content, to align and combine them, and to match them with experimental data. To automate these processes, it is essential to consider semantic annotations, which describe their biological meaning. As a prerequisite for a wide range of computational methods, we propose general and flexible similarity measures for Systems Biology models computed from semantic annotations. By using these measures and a large extensible ontology, we implement a platform that can retrieve, cluster, and align Systems Biology models and experimental data sets. At present, its major application is the search for relevant models in the BioModels Database, starting from initial models, data sets, or lists of biological concepts. Beyond similarity searches, the representation of models by semantic feature vectors may pave the way for visualisation, exploration, and statistical analysis of large collections of models and corresponding data.

With the advances in medicine, people have deeply understood the complex pathogenesis of diseases. Revealing the mechanism of action and therapeutic effect of drugs from an overall perspective has become the top priority of drug design. However, the traditional drug design methods cannot meet the current needs. In recent years, with the rapid development of systems biology, a variety of new technologies including metabolomics, genomics, and proteomics have been used in drug research and development. As a bridge between traditional pharmaceutical theory and modern science, computer-aided drug design(CADD) can shorten the drug development cycle and improve the success rate of drug design. The application of systems biology and CADD provides a methodological basis and direction for revealing the mechanism and action of drugs from an overall perspective. This paper introduces the research and application of systems biology in CADD from different perspectives and proposes the development direction, providing reference for promoting the application.

Calcific aortic valve disease (CAVD) arises from coupled interactions between blood flow, tissue mechanics, and cellular signaling. Hemodynamic forces influence endothelial and interstitial cell behavior, while the resulting tissue remodeling alters valve motion and flow patterns. Capturing this two-way feedback requires models that integrate fluid-structure mechanics with biochemical regulation, yet such multiscale coupling remains technically challenging. Previous computational models have focused on isolated aspects of the disease: fluid-structure interaction (FSI) simulations reproduce valve deformation and flow, and systems biology (SB) models describe molecular signaling that drives fibrosis and calcification. However, without coupling, these approaches cannot predict how mechanical dysfunction initiates biochemical remodeling or how biochemical changes feed back on mechanics. Here, we present a multi-physics computational framework that couples three-dimensional FSI simulations of aortic valve dynamics with a mechanistic SB model of calcification signaling. The FSI module resolves pulsatile blood flow and leaflet deformation, yielding local wall shear stresses and tissue strains throughout the cardiac cycle. These mechanical quantities are used as inputs to the SB module, which represents key biochemical pathways governing inflammation, TGF- β /SMAD signaling, and nitric-oxide (NO)-mediated inhibition within valvular cells. Simulations predict long-term calcification trajectories for valves of varying thickness, showing that fibrosis-induced stiffening lowers shear stress, reduces NO synthesis, and enhances TGF- β activation, thereby accelerating calcification. The framework is modular and extensible, allowing future incorporation of additional pathways, as well as implementation of full two-way coupling between the FSI and SB models. By integrating physics-based hemodynamics with systems-level biochemistry, this study provides a proof-of-principle demonstration of a next-generation, multi-scale modeling platform for studying cardiovascular disease that unites blood flow dynamics and biochemical signaling.

In this paper, we have overviewed deterministic and stochastic approaches for the modeling of bio-molecular reactions in systems biology. We have described and compared different versions of stochastic simulation approaches towards the modeling of bio-molecular reaction systems, the direct approach and the family of the tauleap methods. We also have illustrated differences between different approaches by providing numerical examples of computational analyses for selected models. Computational examples of application of stochastic simulation algorithms involved two systems of different interacting bio-molecular species and one model from the area of ecology, describing interactions between two animal populations. Apart from the direct approach and tau-leap family of methods, we have also overviewed the so called hybrid algorithm of stochastic simulations, proven to be very efficient when there are huge differences between reaction rates in the system.

In this article I address the interactions between biological knowledge and ideas about the kinds of entity that are suited to appropriation. I start by arguing that commodification and reductionism are closely linked, and that patenting suits entities that are discrete and isolable, such as those that are the focus of molecular biology. I then turn to the new field of systems biology, which recognizes that traditional reductionist approaches to biology are no longer adequate and attempts to provide a more integrative understanding of biological systems. In doing this, systems biology has to deal with emergent phenomena. But patenting does not suit the dynamic and interactive complexity that is the object of study in systems biology. If systems biology rejects reductionism where does that leave commodification? I examine attempts to commodify predictive computational models in systems biology. I then turn to systems biology's sister discipline, synthetic biology, which deals with emergence by reducing the complexity of biological systems. By factoring out messy contingencies, synthetic biology is, in theory, well suited to commodification. Drawing on both these examples I explore how ideas about appropriation, including open source, are influencing the nature and course of research in biology.

Single-molecule imaging of fluorescently labeled biomolecules is a powerful technique for measuring association interactions; however, care must be taken to ensure that the fluorescent labels do not influence the system being probed. Label-free techniques are needed to understand biomolecule interactions free from the influence of an attached label, but these techniques often lack sensitivity and specificity. To solve these challenges, we have developed a competitive assay that uses single-molecule detection to track the population of unlabeled target single-stranded DNA (ssDNA) hybridized with probe DNA immobilized at a glass interface by detecting individual duplexes with a fluorescently labeled "tracer" ssDNA. By labeling a small fraction (<0.2%) of target molecules, the "tracer" DNA tracks the available probe DNA sites without significant competition with the unlabeled target population. Single-molecule fluorescence imaging is a good read-out scheme for competitive assays, as it is sufficiently sensitive to detect tracer DNA on substrates with relatively low densities of probe DNA, ∼10(-3) of a monolayer, so that steric interactions do not hinder DNA hybridization. Competitive assays are used to measure the association constant of complementary strand DNA hybridization of 9- and 10-base pair targets, where the tracer assay predicts the same association constant as a traditional displacement competitive assay. This methodology was used to compare the Ka of hybridization for identical DNA strands differing only by the presence of a fluorescent label tethered to the 5' end of the solution-phase target. The addition of the fluorescent label significantly stabilizes the DNA duplex by 3.6 kJmol(-1), adding more stability than an additional adenine-thymine base-pairing interaction, 2.7 kJmol(-1). This competitive tracer assay could be used to screen a number of labeled and unlabeled target DNA strands to measure the impact of fluorescent labeling on duplex stability. This single-molecule competitive hybridization scheme could be easily adapted into a sensitive assay, where competition between tracer and target oligonucleotides for probe sites could be used to measure concentrations of unlabeled DNA or RNA.

Advanced imaging techniques for studying protein phase separation in living cells and at single-molecule level

Chemical reactions are rearrangements of chemical bonds. Each atom in an educt molecule thus appears again in a specific position of one of the reaction products. This bijection between educt and product atoms is not reported by chemical reaction databases, however, so that the “Atom Mapping Problem” of finding this bijection is left as an important computational task for many practical applications in computational chemistry and systems biology. Elementary chemical reactions feature a cyclic imaginary transition state (ITS) that imposes additional restrictions on the bijection between educt and product atoms that are not taken into account by previous approaches. We demonstrate that Constraint Programming is well-suited to solving the Atom Mapping Problem in this setting. The performance of our approach is evaluated for a manually curated subset of chemical reactions from the KEGG database featuring various ITS cycle layouts and reaction mechanisms.Electronic supplementary materialThe online version of this article (doi:10.1186/s13015-014-0023-3) contains supplementary material, which is available to authorized users.

Prediction and control sufficient for reliable medical and other interventions are prominent aims of modeling in systems biology. The short-term attainment of these goals has played a strong role in projecting the importance and value of the field. In this paper I identify the standard models must meet to achieve these objectives as predictive robustness—predictive reliability over large domains. Drawing on the results of an ethnographic investigation and various studies in the systems biology literature, I explore four current obstacles to achieving predictive robustness; data constraints, parameter uncertainty, collaborative constraints and system-scale requirements. I use a case study and the commentary of systems biologists themselves to show that current practices in the field, rather than pursuing these goals, frequently use models heuristically to investigate and build understanding of biological systems that do not meet standards of predictive robustness but are nonetheless effective uses of computation. A more heuristic conception of modeling allows us to interpret current practices as ways that manage these obstacles more effectively, particularly collaborative constraints, such that modelers can in the long-run at least work towards prediction and control.

In his famous essay, Lazebnik [1] discussed whether a biologist can fix a broken radio and suggested that applying the ‘biologist approach’ to a broken radio will likely not lead to a successful end, while any engineer or even a trained repairman evidently could fix the radio. In biology, the study of molecules one by one is fine for gathering information on how molecules work, but deciphering biological mechanisms, or the function of biological systems, is a different story. One difference between an engineer and a biologist, according to Lazebnik, lies in the language: in biology, language is oftentimes vague and nonquantitative which limits the possibility of making predictions [1]. In systems biology, a quantitative and predictive language is adopted to describe biological knowledge in order to understand how molecules act together within the network of interactions that makes up a living system. Systems biology, in other words, is the holistic analysis of complex systems. Indeed, systems biology can be defined as the computational and mathematical modeling of complex biological systems, in contrast to the traditional, reductionist approach to biology. Common technology platforms that are deployed to obtain complex datasets are transcriptomics, proteomics, metabolomics and epigenomics. However, systems biology should not be seen merely as the generation of lists of genes, proteins or metabolites using such omics platforms; the objective is to exploit these data and to develop quantitative models that describe the biological system and its response to individual perturbations (see [2] for an excellent introduction to this subject). Furthermore, systems biology can be seen as an iterative interplay between discoveryand hypothesis-driven science: “global observations (discoveries) are matched against model predictions (hypotheses) in an iterative manner, leading to the formation of new models, new predictions, and new experiments to test them” [2]. Systems toxicology, in turn, has been described as “the integration of classical toxicology with quantitative analysis of large networks of molecular and functional changes occurring across multiple levels of biological organization”, and it has been suggested that its application could be part of a new and improved risk assessment [3]. This is nothing less than a paradigm shift in the way that toxicology is conducted. Importantly, systems toxicology – and systems biology in general – relies heavily on computational approaches to manage, analyze and interpret the data generated by large-scale experiments, and computer databases are thus an integral feature of this approach [2]. To this end, commonly accepted repositories and software environments are crucially important [4]. This does not mean that the introduction of systems toxicology approaches is breaking the rice bowl of the classically trained toxicologist. Instead, the ‘new’ toxicology is Systems biology in nanosafety research

Computer Science and Systems Biology have heralded remarkable technological advances in understanding the complex biological systems including human biochemical, molecular and neural pathways and networks. Systems biology integrates the computer applications and experimental biology in modeling’s, predictions and characterizations of complex and dynamic properties of biological systems. Particularly, multi-omics studies, high-throughput sequencing techniques and microarray techniques made possible the generation of large datasets from biological systems that could help in understanding the comprehensive molecular pathways, systems functions and behaviors. In the last decade, the computer science and systems biology approaches increased the interest in pathway based biomarker identification, identifying disease genes and drug targets, generation of global genetic interaction maps, and development of new diagnosis and therapeutics methods for deadly diseases and contemporary outbreaks. In this letter, I summarize the breakthroughs of the decade and future challenges in uncover the complex components of biological systems.

An important and challenging problem in systems biology is the inference of gene regulatory networks from short non-stationary time series of transcriptional profiles. A popular approach that has been widely applied to this end is based on dynamic Bayesian networks (DBNs), although traditional homogeneous DBNs fail to model the non-stationarity and time-varying nature of the gene regulatory processes. Various authors have therefore recently proposed combining DBNs with multiple changepoint processes to obtain time varying dynamic Bayesian networks (TV-DBNs). However, TV-DBNs are not without problems. Gene expression time series are typically short, which leaves the model over-flexible, leading to over-fitting or inflated inference uncertainty. In the present paper, we introduce a Bayesian regularization scheme that addresses this difficulty. Our approach is based on the rationale that changes in gene regulatory processes appear gradually during an organism's life cycle or in response to a changing environment, and we have integrated this notion in the prior distribution of the TV-DBN parameters. We have extensively tested our regularized TV-DBN model on synthetic data, in which we have simulated short non-homogeneous time series produced from a system subject to gradual change. We have then applied our method to real-world gene expression time series, measured during the life cycle of Drosophila melanogaster, under artificially generated constant light condition in Arabidopsis thaliana, and from a synthetically designed strain of Saccharomyces cerevisiae exposed to a changing environment.

Living cells can be observed as complex dynamical systems that are constantly remodelling themselves as response to changes in their environment (Zak et al., 2005). The cell metabolism includes number of reactions and products of reactions which interact forming a metabolic network. Due to the fact that large amount of date about processes in living cells are being collected every day, it become necessary to use computers for data processing and analysis. Introducing computer technologies into biology new discipline has been develop, systems biology or computational biology. The aim of system biology is describing and understanding how parts of organism interact in one complex system ; systems biology aims to develop mathematical model of biological systems by integrating experimental and theoretical techniques (Hecker et al., 2009, Albert, 2004). Systems biology studies biological systems by systematically perturbating them (biologically, genetically or chemically) monitoring the genes, proteins and informational pathway response (Strizh et al., 2007). Progress in molecular biology led to development of complete maps of genomes of many organisms ; it is also possible to identify and classify proteins. Although the number of completely sequenced genomes is mounting rapidly, our knowledge of transcription regulation is limited to a few model organisms (Janga and Collado-Vides, 2007). The interactive regulation of genes, working together to create gene networks has been considered the origin of many functions of organism (Mochizuki, 2008). According to Bruggeman and Westerholl, a complete systems biology approach requires (i) characterisation of organism molecular composition, (ii) components dynamics (spatial and temporal) and (iii) detail analysis of molecular response to internal and external stimuli. All these facts are included in development of gene regulatory network. In this chapter the theory of gene regulatory networks will be presented. The chapter will start with ideas how gene regulatory networks are constructed. There will be data on different types of gene regulatory networks and approaches for modeling those systems. This chapter will try to explain why is the modeling of complex regulatory networks important for genetic engineering and how can the mathematical analysis of gene regulatory networks be used for genetic engineering experiments planning and results interpretation.